Skip to content

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02445885
Acronym
LATE-MI
Enrollment
150
Registered
2015-05-15
Start date
2015-05-01
Completion date
2026-05-13
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease, ST-segment Elevation Myocardial Infarction

Keywords

Myocardial infarction, Late presenters, Primary percutaneous coronary intervention, Reperfusion, Angioplasty, Duration of ischemia, Cardiovascular magnetic resonance imaging

Brief summary

Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains unestablished whether patients with a symptom duration of more 12 hours benefit from acute revascularisation. This study aims to investigate whether acute intervention is superior to subacute intervention in these patients.

Detailed description

The recommended therapy for patients with ST-segment elevation myocardial infarction (STEMI) is to restore normal coronary blood flow with timely reperfusion by percutaneous coronary intervention (PCI), and thereby minimize the extent of cell death and preserving cardiac function. The duration of ischemia and timely PCI are major determinants for the size of the myocardial infarction and prognosis. Thus, acute PCI should be performed within 12 hours after symptom onset. The effect of PCI and timing of PCI are, however, much more uncertain for late presenters who contact the health service \> 12 hours from symptom. Thus, it is still unknown whether late presenters should be treated with acute PCI or medical treatment with delayed PCI (24-72 h after first medical contact). The study investigates the effect on final salvage index evaluated by magnetic resonance imaging of acute PCI of late presenters. The overall objective of the study is to investigate whether late presenters may benefit from acute PCI, and thus whether to extend the currently recommended time limit of 12 hours for acute PCI in patients with STEMI.

Interventions

PROCEDUREPCI

Guideline directed Percutaneous Coronary Intervention

Sponsors

Thomas Engstrom
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria: * Patients more than 18 years of age. * STEMI \> 12 hours and \< 36 hours. * Clinical stable, i.e. no on going angina, hemodynamically stable (systolic BP \> 90) and Killip class \< 3.

Exclusion criteria

* Clinical instability which requires an acute invasive strategy. * Left main occlusion or multivessel disease which requires CABG. * Previous Q-wave infarction in the current infarct related artery. * Left Bundle Branch Block (LBBB). * Severe renal insufficiency. * Pacemaker * Chronic atrial fibrillation. * Previous Coronary Artery Bypass Surgery (CABG). * Pregnancy. * Other severe illness with life expectancy less than 1 year

Design outcomes

Primary

MeasureTime frameDescription
Acute salvage index evaluated by MRI1-2 daysMRI within 48 timer after index admission will be used to measure are at risk (AAR, T2-weighted) and acute infarct size (IZ). Acute salvage index is (AAR-IZ)/AAR

Secondary

MeasureTime frameDescription
Final infarct size3 monthsPlease see above
Final myocardial salvage index1-2 daysAs for primary endpoint but IZ is measured within the index admission
Acute infarct size1-2 days
Microvascular obstruction (MVO)1-2 days
Left Ventricular Ejection Fraction (LVEF)1-2 days and 3 monthsMeasured by MRI
All-cause mortalityUntil last included patient has been followed for 180 daysMortality due to any cause
All-cause mortality and hospitalization for heart failureUntil last included patient has been followed for 180 days
All-cause mortality, hospitalization for heart failure and malignant arrhythmiaUntil last included patient has been followed for 180 days
Cardiac deathUntil last included patient has been followed for 180 daysDeath caused by a malfunction of the heart muscle or electrical system.
Hospitalization for heart failureUntil last included patient has been followed for 180 days
Spontaneous myocardial infarctionUntil last included patient has been followed for 180 days
Malignant arrhythmiaUntil last included patient has been followed for 180 daysVF/VT or ICD activation
Unplanned revascularizationUntil last included patient has been followed for 180 daysAny unplanned revascularization
StrokeUntil last included patient has been followed for 180 daysAny stroke or TIA

Countries

Denmark

Contacts

PRINCIPAL_INVESTIGATORLars Nepper-Christensen, MD

Rigshospitalet, Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026